Peter Ogram

Global Executive VP, Business Development Tanner Pharma Group

Seminars

Thursday 16th July 2026
Designing a For-Charge Expanded Access Programme: The Role of Medical & Clinical Teams
9:30 am

In this interactive working session, attendees will explore how Medical and Clinical teams can help shape the design of a for-charge Expanded Access Programme once the decision to charge has been made. Drawing on real-world experience, the session will focus on the practical safeguards, considerations, and cross-functional decisions that ensure programmes remain patient-centric, ethical, and operationally sustainable. Participants will:

  • Explore the key design considerations Medical and Clinical teams should influence when supporting a for-charge programme
  • Discuss common safeguards, funding considerations, and patient access challenges that can impact programme design
  • Assess and prioritise practical programme components through table-based discussion and peer benchmarking
  • Leave with a framework of considerations they can take back to internal discussions around for-charge EAP strategy
Peter Ogram - Executive Vice President, Global Business Development - Tanner Pharma